Russia completes early trials of second potential COVID-19 vaccine - Ifax - (This is Money via NewsPoints Desk)

  • Siberia's Vector virology institute has completed Phase II testing of a second potential Russian vaccine against COVID-19, as reported in This is Money.

  • "Today... the final group of 20 volunteers was released from hospital," state consumer safety watchdog Rospotrebnadzor said.

  • It added that "all 100 volunteers were vaccinated with two doses and have completed a 23-day monitoring period in hospital. The volunteers are feeling good."

To read more NewsPoints articles, click here.